We describe the first public data release of the Dark Energy Survey, DES DR1, consisting of reduced single-epoch images, co-added images, co-added source catalogs, and associated products and services assembled over the first 3 yr of DES science operations. DES DR1 is based on optical/near-infrared imaging from 345 distinct nights (2013 August to 2016 February) by the Dark Energy Camera mounted on the 4 m Blanco telescope at the Cerro Tololo Inter-American Observatory in Chile. We release data from the DES wide-area survey covering ∼5000 deg 2 of the southern Galactic cap in five broad photometric bands, grizY. DES DR1 has a median delivered point-spread function of = g 1.12, r=0.96, i=0.88, z=0.84, and Y=0 90 FWHM, a photometric precision of <1% in all bands, and an astrometric precision of 151 mas. The median co-added catalog depth for a 1 95 diameter aperture at signal-to-noise ratio (S/N)=10 is g=24.33, r=24.08, i=23.44, z=22.69, and Y=21.44 mag. DES DR1 includes nearly 400 million distinct astronomical objects detected in ∼10,000 co-add tiles of size 0.534 deg 2 produced from ∼39,000 individual exposures. Benchmark galaxy and stellar samples contain ∼310 million and ∼80 million objects, respectively, following a basic object quality selection. These data are accessible through a range of interfaces, including query web clients, image cutout servers, jupyter notebooks, and an interactive co-add image visualization tool. DES DR1 constitutes the largest photometric data set to date at the achieved depth and photometric precision.

We study the magnetoimpedance effect, using a Co67Fe4Mo1.5Si16.5B11 amorphous, ribbon-based sensitive element, in the presence of a commercial Ferrofluid® liquid thin layer covering the ribbon surface. The magnetoimpedance response is clearly dependent on the presence of the magnetic ferroliquid, the value of the applied magnetic field, and the parameters of the driving current. The magnetoimpedance-based prototype is proposed as a biosensor with high sensitivity to the fringe field produced by magnetic nanoparticles. A special advantage of this sensor is its high stability to chemical aggressive media; hence, it can be used for in situ measurements during fabrication of biomaterials with a high level of affinity and specificity with nanoparticles employed as bimolecular labels.

No abstract

No abstract

The giant magneto-impedance effect ͑GMI͒ is studied as a function of the structural modification induced in an Fe 73.5 Si 13.5 B 9 Cu 1 Nb 3 amorphous alloy wire by annealing. The values of GMI are correlated to those structural changes and with the corresponding variation of the magnetic properties and intrinsic resistivity. Excellent soft magnetic properties, associated with low resistivity values, make this nanostructured material as one of the most promising for future applications of the GMI effect. The tailoring of the structure which can be induced by adequate thermal treatments easily allows one to obtain excellent combinations of circumferential permeability and resistivity during different devitrification stages, in order to produce materials for specific aims. Maximum GMI ratios of 200% are found after annealing the wires in the range 550-600°C, where an optimum compromise between and is found. A simple model is developed correlating the fundamental physical properties of the soft magnetic wires with the measured values of both components of the impedance, allowing the prediction of experimental GMI ratios and an easy visualization of the phenomenon.

Latest studies on the chemical association of trace elements to large biomolecules and their importance on the bioinorganic and clinical fields are examined. The complexity of the speciation of metal-biomolecules associations in various biological fluids is stressed. Analytical strategies to tackle speciation analysis and the-state-of-the-art of the instrumentation employed for this purpose are critically reviewed. Hyphenated techniques based on coupling chromatographic separation techniques with ICP-MS detection are now established as the most realistic and potent analytical tools available for real-life speciation analysis. Therefore, the status and potential of metal and semimetals elemental speciation in large biocompounds using ICP-MS detection is mainly focused here by reviewing reported metallo-complexes separations using size-exclusion (SEC), ion-exchange (IE), reverse phase chromatography (RP) and capillary electrophoresis (CE). Species of interest include coordination complexes of metals with larger proteins (e.g. in serum, breat milk, etc.) and metallothioneins (e.g. in cytosols from animals and plants) as well as selenoproteins (e.g. in nutritional supplements), DNA-cisplatin adducts and metal/semimetal binding to carbohydrates. An effort is made to assess the potential of present trace elements speciation knowledge and techniques for "heteroatom-tagged" (via ICP-MS) proteomics.

No abstract

Around 40% of the population will suffer at some point in their life a disease involving tissue loss or an inflammatory or autoimmune process that cannot be satisfactorily controlled with current therapies. An alternative for these processes is represented by stem cells and, especially, mesenchymal stem cells (MSC). Numerous preclinical studies have shown MSC to have therapeutic effects in different clinical conditions, probably due to their mesodermal origin. Thereby, MSC appear to play a central role in the control of a galaxy of intercellular signals of anti-inflammatory, regenerative, angiogenic, anti-fibrotic, anti-oxidative stress effects of anti-apoptotic, anti-tumor, or anti-microbial type. This concept forces us to return to the origin of natural physiological processes as a starting point to understand the evolution of MSC therapy in the field of regenerative medicine. These biological effects, demonstrated in countless preclinical studies, justify their first clinical applications, and draw a horizon of new therapeutic strategies. However, several limitations of MSC as cell therapy are recognized, such as safety issues, handling difficulties for therapeutic purposes, and high economic cost. For these reasons, there is an ongoing tendency to consider the use of MSC-derived secretome products as a therapeutic tool, since they reproduce the effects of their parent cells. However, it will be necessary to resolve key aspects, such as the choice of the ideal type of MSC according to their origin for each therapeutic indication and the implementation of new standardized production strategies. Therefore, stem cell science based on an intelligently designed production of MSC and or their derivative products will be able to advance towards an innovative and more personalized medical biotechnology.